Additionally, when the capacity of REST to inhibit the phosphoinositide-3-kinase (PI3K) pathway is inhibited in cancer cells due to its degradation through βTrCP activity, this is proposed to result in increased cell transformations [13,24]. The gene discussed is BTRC; the disease is cancer.